Cassidy criticizes Trump’s FDA pick, says her role in vaccine order is ‘almost disqualifying’
Cassidy said Overton’s role in the childhood vaccine order is almost disqualifying and questioned her management experience as she seeks Senate confirmation.
- On Wednesday, President Trump announced his nomination of White House domestic policy adviser Dr. Heidi Overton to lead the Food and Drug Administration , drawing immediate hostile opposition from Senate Health Committee Chair Bill Cassidy.
- Cassidy labeled Overton's involvement in the administration's executive order last week to reduce childhood vaccines from 18 to 11 as "almost disqualifying" for the position.
- Arguing the vaccine policy is "nonsensical," Cassidy said Overton's actions raise doubts about her commitment to "sound science" and children's health, while questioning her management background for the sprawling agency.
- Trump and Health and Human Services Secretary Robert F. Kennedy Jr. defend Overton as a "ROCKSTAR," though some MAHA activists remain skeptical, viewing her as too embedded in the traditional public health establishment.
- Confirmation requires approval from Cassidy's committee, while White House spokesman Kush Desai claimed Overton "has played an integral role in nearly every single MAHA policy victory by the Trump administration.
32 Articles
32 Articles
White House to press forward with FDA nominee despite US Senate chairman’s concerns • Maine Morning Star
Louisiana Republican U.S. Sen. Bill Cassidy talks with reporters in the Dirksen Senate office building on Wednesday, Dec. 3, 2025. (Photo by Jennifer Shutt/States Newsroom)WASHINGTON — President Donald Trump’s nominee to lead the Food and Drug Administration will face challenges securing Senate confirmation after the committee chairman in charge of that process expressed doubts. That, however, hasn’t deterred White House officials from pressing…
White House to press forward with FDA nominee despite US Senate chairman’s concerns • West Virginia Watch
Louisiana Republican U.S. Sen. Bill Cassidy talks with reporters in the Dirksen Senate office building on Wednesday, Dec. 3, 2025. (Photo by Jennifer Shutt/States Newsroom)WASHINGTON — President Donald Trump’s nominee to lead the Food and Drug Administration will face challenges securing Senate confirmation after the committee chairman in charge of that process expressed doubts. That, however, hasn’t deterred White House officials from pressing…
Louisiana’s Bill Cassidy questions Trump FDA nominee’s experience, vaccine stance
WASHINGTON – U.S. Sen. Bill Cassidy has raised concerns about President Donald Trump’s nominee to run the agency that oversees the safety of food and drugs, citing a lack of experience and questioning her commitment to defending vaccines.
White House to press forward with FDA nominee despite Cassidy’s concerns
Louisiana Republican U.S. Sen. Bill Cassidy talks with reporters in the Dirksen Senate office building on Wednesday, Dec. 3, 2025. (Photo by Jennifer Shutt/States Newsroom)WASHINGTON — President Donald Trump’s nominee to lead the Food and Drug Administration will face challenges securing Senate confirmation after the committee chairman in charge of that process expressed doubts. That, however, hasn’t deterred White House officials from pressing…
Iowa Capital Dispatch
White House to press forward with FDA nominee despite US Senate chairman’s concerns
Louisiana Republican U.S. Sen. Bill Cassidy talks with reporters in the Dirksen Senate office building on Wednesday, Dec. 3, 2025. (Photo by Jennifer Shutt/States Newsroom)WASHINGTON — President Donald Trump’s nominee to lead the Food and Drug Administration will face challenges securing Senate confirmation after the committee chairman in charge of that process expressed doubts. That, however, hasn’t deterred White House officials from pressing…
Coverage Details
Bias Distribution
- 84% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
